First Nebraska Trust Co acquired a new stake in shares of Arcosa, Inc. (NYSE:ACA – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 6,999 shares of the company’s stock, valued at approximately $1,017,000.
A number of other large investors also recently modified their holdings of the company. Castleark Management LLC raised its holdings in Arcosa by 53.9% during the first quarter. Castleark Management LLC now owns 74,650 shares of the company’s stock worth $7,923,000 after buying an additional 26,150 shares during the last quarter. Horizon Investments LLC acquired a new position in shares of Arcosa during the fourth quarter valued at about $1,925,000. Principal Financial Group Inc. grew its holdings in shares of Arcosa by 13.7% during the first quarter. Principal Financial Group Inc. now owns 266,113 shares of the company’s stock valued at $28,245,000 after buying an additional 32,164 shares during the last quarter. Fifth Third Bancorp increased its position in shares of Arcosa by 3,554.1% during the first quarter. Fifth Third Bancorp now owns 13,045 shares of the company’s stock worth $1,385,000 after acquiring an additional 12,688 shares in the last quarter. Finally, BlackRock Inc. bought a new stake in shares of Arcosa during the second quarter worth about $1,222,486,000. 90.66% of the stock is currently owned by institutional investors.
Arcosa Stock Down 0.1%
ACA opened at $145.23 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 3.12 and a quick ratio of 2.31. The company’s 50-day moving average is $143.86 and its 200 day moving average is $126.90. Arcosa, Inc. has a fifty-two week low of $89.03 and a fifty-two week high of $146.92. The firm has a market capitalization of $7.13 billion, a P/E ratio of 14.55, a PEG ratio of 2.18 and a beta of 1.05.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently weighed in on the stock. Barclays upped their target price on shares of Arcosa from $115.00 to $140.00 and gave the stock an “overweight” rating in a report on Monday, May 4th. Stephens set a $150.00 price objective on Arcosa in a report on Thursday, August 6th. Texas Capital downgraded Arcosa from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, June 23rd. Weiss Ratings restated a “hold (c+)” rating on shares of Arcosa in a report on Friday, August 7th. Finally, Oppenheimer cut Arcosa from an “outperform” rating to a “market perform” rating in a research report on Friday, June 26th. Two research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, Arcosa has a consensus rating of “Hold” and an average target price of $141.25.
Get Our Latest Analysis on ACA
About Arcosa
Arcosa, Inc (NYSE: ACA) is a Dallas?based industrial company that was formed through the spin?off of Trinity Industries’ construction products business in 2018. Since its inception, Arcosa has focused on the manufacture and sale of critical infrastructure components, serving a diverse set of end markets including transportation, construction and energy.
The company’s Construction Products segment produces a broad range of highway safety products, such as guardrail systems, sign supports and crash cushions, as well as aggregates and ready?mix concrete.
Featured Articles
- Five stocks we like better than Arcosa
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding ACA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arcosa, Inc. (NYSE:ACA – Free Report).
Receive News & Ratings for Arcosa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcosa and related companies with MarketBeat.com's FREE daily email newsletter.
